FSD Pharma
Dr. Lakshmi Kotra, Senior Scientist at Krembil Brain Institute, University Health Network (UHN), and Professor of Medicinal Chemistry at the University of Toronto, joined FSD Pharma as CEO of its wholly-owned subsidiary, Lucid, upon completion of its acquisition of Lucid Psycheceuticals in September 2021.
This person is not in the org chart
This person is not in any offices
FSD Pharma
FSD Pharma is committed to the pursuit of developing innovative novel biotechnologies to bring advanced neurodegenerative and mental health treatments to market.